Regarding the mechanisms underlying the effects of Gal–1 on cardiac cells, it is well known that galectins can act by blocking or stimulating pathogen attachment and infection through binding to host or microbial glycans, or by interfering with molecular interactions required for microbial entry to host cells [42]. The gene discussed is LGALS1; the disease is infection.